Funded Tech Companies
Boston Immune Technologies and Therapeutics
Wondering who provided funding to Boston Immune Technologies and Therapeutics? BeiGene, EGP Investments and Hatteras Venture Partners joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Boston Immune Technologies and Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
81 Walnut St.
Winchester, MA 01890
USA
Winchester, MA 01890
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Boston Immune Technologies and Therapeutics (BITT) is a Boston, MA based company developing a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/18/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell LaMontagne
Chief Medical Officer
Samson Fung
VP - Finance
Elena Ende
VP - General Counsel
Steve Andress
Company Investors
Browse more funded tech companies:
Boston Heart Diagnostics | Boston Materials
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs